Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 181 entries
View as:

Investigating the Pharmacokinetic Drug Interactions Between HGP1201 and HGP0904

Phase: N/A Priority: Normal
NCT ID: NCT02243319 Org: User:
Start: 09/30/14 End: 12/31/14 Due: 12/31/15

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH

Phase: N/A Priority: Normal
NCT ID: NCT02390882 Org: User:
Start: 10/31/14 End: 07/31/15 Due: 07/31/16

Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 10mg

Phase: N/A Priority: Normal
NCT ID: NCT02026817 Org: User:
Start: 12/31/13 End: 01/31/14 Due: 01/31/15

Efficacy/Safety of Amlodipine Plus Losartan Versus Losartan in Patients With Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00940680 Org: User:
Start: 04/30/08 End: 11/30/08 Due: 11/30/09

Food-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03882112 Org: User:
Start: 04/17/19 End: 08/28/19 Due: 08/28/20

A Study to Evaluate Efficacy and Safety of HGP2102 in Essential Hypertension Patients

Phase: N/A Priority: Normal
NCT ID: NCT06174766 Org: User:
Start: 05/10/24 End: 12/31/26 Due: 12/31/27

Clinical Trial to Evaluate the Effect on the Pharmacokinetic Characteristics of HCP1007 Capsule

Phase: N/A Priority: Normal
NCT ID: NCT01548157 Org: User:
Start: 03/31/12 End: 12/31/12 Due: 12/31/13

Duration of P-glycoprotein Inhibition After Oral Administration of HM30181AK Tablet

Phase: N/A Priority: Normal
NCT ID: NCT00954304 Org: User:
Start: 06/30/09 End: 09/30/09 Due: 09/30/10

Dose Escalation and Expansion Study of HM16390 in Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06724016 Org: User:
Start: 12/11/24 End: 03/31/30 Due: 03/31/31

An Observational Study to Evaluate Effectiveness and Safety of Amosartan Q Tablet

Phase: N/A Priority: Normal
NCT ID: NCT05450575 Org: User:
Start: 04/17/18 End: 07/20/21 Due: 07/20/22

A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06346184 Org: User:
Start: 05/02/24 End: 06/10/24 Due: 06/10/25

A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM15211(Efocipegtrutide)

Phase: N/A Priority: Normal
NCT ID: NCT03374241 Org: User:
Start: 04/04/18 End: 09/14/18 Due: 09/14/19

Safety to Evaluate the Efficacy and Safety of HIP1601 in Patients With Non Erosive Reflux Disease

Phase: N/A Priority: Normal
NCT ID: NCT04325620 Org: User:
Start: 06/10/19 End: 08/03/20 Due: 08/03/21

Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02057172 Org: User:
Start: 01/31/14 End: 12/31/14 Due: 12/31/15

Evaluating the Bioequivalence of HIP1403, HGP0919

Phase: N/A Priority: Normal
NCT ID: NCT02473900 Org: User:
Start: 04/30/15 End: 04/30/15 Due: 04/30/16

An Observational Study to Evaluate the Treatment of Newvast® Tab(Atorvastatin) in Korean Patients With Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT05555238 Org: User:
Start: 01/16/20 End: 01/27/22 Due: 01/27/23

A Drug-Drug Interaction Study of Ambroxol and Levodropropizine

Phase: N/A Priority: Normal
NCT ID: NCT01573663 Org: User:
Start: 02/29/12 End: 04/30/12 Due: 04/30/13

Diurnal Variation in Hypertensive Stroke Patients

Phase: N/A Priority: Normal
NCT ID: NCT01830517 Org: User:
Start: 08/31/07 End: 02/29/12 Due: 02/28/13

Evaluating a Pharmacokinetic Drug Interaction Between HGP0918 and HGP0816

Phase: N/A Priority: Normal
NCT ID: NCT02554136 Org: User:
Start: 07/31/15 End: 08/31/15 Due: 08/31/16

Pharmacokinetics and Safety of HCP1105 and Co-administration of HGP0918, HGP0816 in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02941796 Org: User:
Start: 06/30/16 End: 10/31/16 Due: 10/31/17

Statin Monotherapy and Rosuzet Tab.(Rosuvastatin/Ezetimibe) Administration in Patients With Dyslipidemia in Korea

Phase: N/A Priority: Normal
NCT ID: NCT04829149 Org: User:
Start: 06/14/16 End: 08/29/19 Due: 08/29/20

Phase 1 Study of PK and Safety of HM15912 (Sonefpeglutide) in Subjects With Normal and Severe Kidney Function

Phase: N/A Priority: Normal
NCT ID: NCT05711381 Org: User:
Start: 12/02/22 End: 08/15/23 Due: 08/15/24

Evaluating a Pharmacokinetic Drug Interaction Between Metformin Hydrochloride and Rosuvastatin Calcium

Phase: N/A Priority: Normal
NCT ID: NCT01775579 Org: User:
Start: 01/31/13 End: 06/30/13 Due: 06/30/14

Comparing Efficacy and Safety Between Eperisone a BID and a TID Regimen in Acute Low Back Pain Patients

Phase: N/A Priority: Normal
NCT ID: NCT01806818 Org: User:
Start: 02/28/13 End: 07/31/13 Due: 07/31/14

A Study to Evaluate the Pharmacokinetics and Safety Between HCP1902 and Co-administration of RLD2007, RLD2008

Phase: N/A Priority: Normal
NCT ID: NCT04946903 Org: User:
Start: 06/10/21 End: 08/10/21 Due: 08/10/22